Vaccination

New Jersey enters the top 10 of total vaccines administered.

China has overtaken the US and is currently leading all countries in total vaccine administrations.

In vitro data suggest the more transmissible mutations of the virus are nonetheless prevented by the mRNA vaccine.

In nearly 1.9 million doses of the COVID-19 vaccine there has been only 21 total cases of anaphylaxis.

A lipidologist from Connecticut describes his experience during the COVID-19 pandemic and explains why he sees getting the vaccine as his "biggest contribution" to healthcare during the pandemic.

There are currently 14 states with laws either encouraging or requiring influenza vaccination for hospital workers.

A narrative has depicted a pandemic situation that is completely negative. There is another way to tell the story of the past nine months.

The US currently leads all countries in total vaccine administrations as of the first week of 2021.

The authorization to Moderna is the second in as many weeks for a COVID-19 vaccine, following Pfizer's.

There were similar rates of primary outcome events in the high-dose and standard-dose vaccination groups.

Throughout the COVID-19 pandemic, the US has shown its lessening interest in mitigating the more manageable virus, influenza. Is there a chance to change course?

Those with a history of severe allergic reaction to vaccines are recommended to consider deferring on the recently approved COVID-19 vaccine.

The VRBPAC committee voted 17-4, with 1 abstention, to support the benefit-risk profile of BNT162b2 for preventing COVID-19 in persons aged 16 years and older.

The newest indication coincides with growing concerns that COVID-19 and flu spread will cause unprecedented burden on the US this winter.

Preliminary data from a phase 3 trial has met its trigger point in total COVID-19 infections, and the interim findings look good for mRNA-1273.

Only 13% of 11,277 pregnant women received the influenza vaccine prior to the 2017 or 2018 influenza seasons.

The trial was called off because of futility of the toxoid vaccine candidate.

Approximately 11.7% of nearly 90,000 hospitalized patients with confirmed influenza suffered from an acute cardiovascular event.

A famed virologist weighs in on the country's earliest shortcomings—and how they can still be resolved today.

The vaccine induced T cell response in about 2 weeks, and antibody response in about 4 weeks, among 1000-plus healthy adults.

Why the virus is burdening US populations similar to other diseases.

Older patients with no stroke history are shown to have reduced risk for both shingles and stroke in new CDC data.

Seqirus announced approval of influenza A monovalent vaccine, adjuvanted (Audenz™) for protection against influenza A in a release on Monday morning.

New data for the 2019-2020 season shows the virus is at a high activity, but disease severity is moderate.

Though vaccination rates are decreasing in children and adolescents overall, it is not due to consideration of previous season's successes or failures.

Renowned infectious disease expert Leonard Calabrese, DO, professor of medicine at the Cleveland Clinic Lerner College of Medicine, takes part in a Q&A on vaccinations in immunocompromised patient populations.

Jeffrey Curtis, MD, discusses the results of a study he led examining the safety of the zoster vaccine in immunocompromised populations, specifically patienta with rheumatic diseases receiving TNF inhibitors.

Fewer than 2% of all patients hospitalized with pneumonia in 2014 received the vaccination.

Xofluza is currently being evaluated in a phase 3 development program for the reduced transmission of flu from an infected person to healthy people.

The CDC Influenza Division medical director reported new findings at IDWeek showing older patients with influenza subtype A were more likely to be hospitalized.